BRITTANY SEDLACEK: Open Payments
NPI 1831523745 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 25 payments from 11 companies in 2025. Trend: 2023 $2,814 · 2024 $844 · 2025 $830
Food & beverage: $620Consulting: $210
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $282 |
| Amgen Inc. | 8 | $145 |
| ABBVIE INC. | 5 | $114 |
| Janssen Biotech, Inc. | 2 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $73 |
| UCB, Inc. | 1 | $38 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: COSENTYX, TREMFYA, SAPHNELO, RINVOQ, UPLIZNA, SKYRIZI, ENBREL, EVENITY.
Industry payments across AK — which companies pay providers there.
